XOMA Royalty to Present at Investor Conferences in March Feb 18, 2026 04:30PM
TD Cowen Resumes XOMA, Ltd. (XOMA) at Hold Feb 12, 2026 04:32PM
XOMA Royalty completes $4.29 per share acquisition of Generation Bio Feb 9, 2026 09:56AM
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. Feb 9, 2026 09:53AM
XOMA Royalty to acquire Generation Bio for $4.29 per share Dec 15, 2025 05:00PM


Dec 15, 2025 05:00PM XOMA to acquire Generation Bio for $4.29 per share plus contingent payments
Dec 15, 2025 05:00PM XOMA Royalty Enters into Agreement to Acquire Generation Bio
Dec 15, 2025 05:00PM XOMA Royalty Enters into Agreement to Acquire Generation Bio
Feb 24, 2025 04:05PM XOMA Royalty to Present at Investor Conferences in March
Apr 30, 2024 07:30AM XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
Feb 28, 2024 07:30AM XOMA to Present at Upcoming Investor Conferences in March
Feb 28, 2023 07:30AM XOMA to Present at 43rd Annual Cowen Health Care Conference
Feb 28, 2023 07:30AM XOMA to Present at 43rd Annual Cowen Health Care Conference
Mar 1, 2022 07:30AM XOMA to Present at the 42nd Annual Cowen Health Care Conference
Feb 23, 2021 04:05PM XOMA to Present at Upcoming Investor Conferences
Feb 25, 2020 04:30PM XOMA to Present at the Cowen and Company 40th Annual Health Care Conference
Mar 5, 2019 07:00AM XOMA to Present at the Cowen and Company 39th Annual Health Care Conference
Mar 5, 2018 07:00AM XOMA to Present at the Cowen and Company 38th Annual Health Care Conference
Feb 28, 2017 07:00AM XOMA to Present New Strategic Initiatives at the Cowen and Company 37th Annual Health Care Conference
Mar 2, 2016 01:30PM XOMA to Present at the Cowen & Company Health Care Conference
Nov 12, 2015 06:37AM XOMA (XOMA) Enters $75M At- the-Market Sales Agreement
Jul 23, 2015 10:36AM Notable Analyst Rating Changes 7/23: (EMC) (DWA) (UTX) Upgraded; (XOMA) (KERX) (HTZ) Downgraded
Jul 22, 2015 12:57PM Cowen Downgrades XOMA, Ltd. (XOMA) to Market Perform
Jul 9, 2015 12:17PM Streetinsider.com's Hot Lunchtime Reads 7/9: (DVAX) (PG) (SYF) (XOMA)
Jul 9, 2015 11:56AM UPDATE: XOMA (XOMA) Gains in Anticipation of Positive Gevokizumab Data
Jul 9, 2015 07:16AM Cowen Remains Bullish on XOMA (XOMA) Ahead of EYEGUARD-B Data
Feb 18, 2015 12:36PM XOMA to Present at Upcoming Investor Conferences
Dec 9, 2014 09:04AM Xoma (XOMA) Prices $40M Offering of Common Stock and Warrants
Dec 9, 2014 09:00AM XOMA Announces Pricing of $40.0 Million Registered Offering of Common Stock and Warrants
Feb 20, 2014 06:24PM XOMA to Present at Upcoming Investor Conferences
Dec 18, 2013 04:01PM XOMA Announces Closing of the Offering and Exercise of Option
Dec 13, 2013 09:19AM XOMA (XOMA) Prices 9.5M Offering at $5.25/Share
Dec 13, 2013 09:13AM XOMA Announces Pricing of Approximately $50.0 Million Offering of Common Stock
Aug 20, 2013 08:32AM XOMA Corp. (XOMA) Prices 7.6M Offeirng at $3.62/Share
Oct 24, 2012 08:59AM XOMA (XOMA) Prices 13.3M Common Offering at $3/Share
May 14, 2012 11:13AM Notable Analyst Rating Changes 05/14: (STJ) (ACI) (NVDA) Upgraded; (NOK) (JBLU) (SYMC) Downgraded
May 14, 2012 07:58AM Cowen Starts XOMA, Ltd. (XOMA) at Outperform